Myovant Sciences: Fiscal 3Q Earnings Snapshot

LONDON (AP) _ Myovant Sciences Ltd. (MYOV) on Thursday reported a loss of $73.8 million in its fiscal third quarter.

On a per-share basis, the London-based company said it had a loss of 82 cents.

The results topped Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 89 cents per share.

The biopharmaceutical company posted revenue of $1.4 million in the period.

Myovant Sciences shares have decreased 15% since the beginning of the year. The stock has increased 73% in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on MYOV at https://www.zacks.com/ap/MYOV